§ 21-5-404 - Powers -- Functions -- Duties.
21-5-404. Powers -- Functions -- Duties.
The State and Public School Life and Health Insurance Board shall have the following powers, functions, and duties:
(1) To explore various cost-containment measures and funding options;
(2) To promote competition among vendors and create a systematic formula for measuring competitiveness of programs, quality-of-care delivery, portability, and accessibility to and affordability of health care;
(3) To prepare a comprehensive analysis of the various health benefit plan options approved by the board to provide coverage to state and public school employees and retirees, including cost, quality, and access differentials among the various plans as well as any other comparisons of the plans;
(4) To undertake studies and to take any appropriate action that the board determines will promote the financial soundness and overall well-being of the members' health insurance programs;
(5) To establish and set penalties as allowed under 21-5-415;
(6) (A) To develop, with the assistance of the Office of State Procurement of the Department of Finance and Administration, bid specifications and requests for proposals and to evaluate bids and proposals.
(B) However, the board shall allow the office to execute all other actions relating to the purchasing procedures in contracting for consultants, third party administrators, providers, or insurance companies on behalf of the programs;
(7) To evaluate responses to requests for proposals, select contractors for all services, and approve the award of contracts resulting from bids for all health and life insurance offerings for participants;
(8) To perform plan design, summarize plan document approval, including, but not limited to, lifetime limitations, copayments, deductibles, and eligibility rules;
(9) To promote increased access to various health plan options and models;
(10) (A) To direct the office to contract with qualified vendors, as defined by the board, offering the benefit plans prescribed by the board without regard to 19-11-228 or other statutes requiring competitive bidding.
(B) Each contract shall be for a term of at least one (1) year but may be made automatically renewable from term to term in the absence of notice of termination by either party;
(11) (A) To obtain quality-of-care information from systems, networks, hospitals, and clinical providers to inform plan design, plan management, and consumer decisions.
(B) The board shall:
(i) Use accepted national standards for assessment of quality-of-care information provided by systems, networks, hospitals, and clinical providers;
(ii) Be empowered to determine the appropriate use of quality-of-care information and scope of system, network, hospital, and clinical provider accountability;
(iii) Be empowered to request aggregate performance information for patients; and
(iv) Be empowered to publicly report conclusions of quality-of-care assessment; and
(12) To appoint three (3) subcommittees of the board to study and research health and life plan option benefits, formulary management, quality of care provided, and the financial impact of implementing the recommendations made to the board as follows:
(A) (i) The Benefits Subcommittee shall consist of:
(a) Three (3) board members;
(b) Two (2) state employees; and
(c) Two (2) school district employees.
(ii) The Benefits Subcommittee shall review, evaluate, and investigate benefits, new benefit offerings, and annual insurance rates;
(B) (i) The Drug Utilization and Evaluation Subcommittee shall consist of:
(a) Three (3) pharmacists as follows:
(1) The Executive Director of the Arkansas State Board of Pharmacy or his or her pharmacist designee;
(2) The Dean of the University of Arkansas for Medical Sciences College of Pharmacy or his or her pharmacist designee; and
(3) A pharmacist selected by the Arkansas Pharmacists Association;
(b) Four (4) physicians as follows:
(1) The Dean of the University of Arkansas for Medical Sciences College of Medicine or his or her physician designee;
(2) The Associate Medical Director of the University Hospital at the University of Arkansas for Medical Sciences or his or her physician designee;
(3) The Medical Director of the Arkansas Poison & Drug Information Center or his or her physician designee; and
(4) A physician selected by the Arkansas Medical Society;
(c) One (1) registered nurse who is the Dean of the University of Arkansas for Medical Sciences College of Nursing or his or her registered nurse designee; and
(d) One (1) state employee and one (1) public school employee appointed by the board, each of whom shall have expertise in accounting, finance, auditing, or insurance.
(ii) The Drug Utilization and Evaluation Subcommittee shall review drugs for formulary management and evaluate the financial impact of its recommendations; and
(C) (i) The Quality of Care Subcommittee shall consist of:
(a) Three (3) board members;
(b) Two (2) state employees;
(c) Two (2) school district employees;
(d) One (1) representative from the Arkansas Foundation for Medical Care;
(e) One (1) representative from the Arkansas Pharmacists Association;
(f) One (1) representative from the Arkansas Center for Health Improvement;
(g) One (1) representative from the Arkansas Medical Association;
(h) One (1) representative from the Arkansas Osteopathic Medical Association; and
(i) One (1) representative from the Arkansas Hospital Association.
(ii) The Quality of Care Subcommittee may review and recommend quality performance indicators for use, recommend baseline performance goals, recommend alignment of financial incentives to improve performance, and track improvements in delivery of care.